Sir, We apologize for this generic response as
Post# of 807
We apologize for this generic response as we prefer to communicate through our OTC Filings and through Press Releases. We do however realize that given a large number of enquiries from our stockholders; this e mail response was necessary.
We are completing, at this time, our Annual Report with the accompanying (required) Attorney’s Letter and our Q1 Report (to December 31, 2014) which also falls due shortly. The filing of these reports restores the Company to that of a “Current Filer” on the OTC Markets.
To deal with a number of issues raised, we confirm that:-
(a) We did cancel and retire a large number of shares of Common Stock (as filed on the OTC Markets Disclosure Service); our number of outstanding shares as reflected on the OTC Markets, is correct; and
(b) We have no intention of abandoning our planned stock repurchase program; and
(c) We remain “in business” as stated in numerous OTC Markets Disclosure Service Filings with no changes at this time; and
(d) Any changes to our businesses would be immediately filed on the OTC Markets Disclosure Service; and
(e) We will publish a “Management Discussion Filing” on the OTC Markets Disclosure Service, to update our stockholders; this being next week and post the filing of our Annual Report.
GNCC CAPITAL, INC.